Angela G. Hadjipanayis

Multiagent Vaccines Vectored by Venezuelan Equine Encephalitis Virus Replicon Elicits Immune Responses to Marburg Virus and Protection Against Anthrax and Botulinum Neurotoxin in Mice (2007)

Lee, John S., Groebner, Jennifer L., Hadjipanayis, Angela G., Negley, Diane L., Schmaljohn, Alan L., Welkos, Susan L., ...

The development of multiagent vaccines offers the advantage of eliciting protection against multiple diseases with minimal inoculations over a shorter time span. We report here the results of using...

Viral Vectors for Use in the Development of Biodefense Vaccines (1998)

Lee, John S., Hadjipanayis, Angela G., Parker, Michael D.

The heightened concerns about bioterrorism and the use of biowarfare agents have prompted substantial increased efforts towards the development of vaccines against a wide range of organisms, toxins,...

Venezuelan Equine Encephalitis Virus-Vectored Vaccines Protect Mice against Anthrax Spore Challenge

Lee, John S., Hadjipanayis, Angela G., Welkos, Susan L.

Anthrax, a disease usually associated with herbivores, is caused by the bacterium Bacillus anthracis. The current vaccine licensed for human use requires a six-dose primary series and yearly boosters...

Venezuelan Equine Encephalitis Virus-Vectored Vaccines Protect Mice against Anthrax Spore Challenge

Lee, John S., Hadjipanayis, Angela G., Welkos, Susan L.

Anthrax, a disease usually associated with herbivores, is caused by the bacterium Bacillus anthracis. The current vaccine licensed for human use requires a six-dose primary series and yearly boosters...